drugset
drugset / Trial / NCT04607252

Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia

NCT04607252 ↗

Phase 2/3 Terminated 12 enrolled Fudan University
RandomizedParallel-groupDouble-blindTreatment

Summary

To verify whether metformin could improve the effect of progestin as fertility-sparing treatment in patients with atypical endometrial hyperplasia(AEH).

Timeline

Start
2021-01-11
Primary completion
2021-06-03
Completion
2021-06-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Megestrol Acetate Other / unclassified 160 mg Oral
Subject Metformin Small molecule 1500 mg Oral

Indications

atypical endometrial hyperplasia